Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?

International Journal of Cancer - United States
doi 10.1002/ijc.31583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)

PLoS ONE
Multidisciplinary
2013English

Randomized Controlled Trials

Phlebology
MedicineCardiovascular MedicineCardiology
2011English

Randomized Controlled Trials

JAMA - Journal of the American Medical Association
Medicine
2005English

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

American Journal of Ophthalmology
Ophthalmology
2016English

How Should a Clinician Interpret Results of Randomized Controlled Trials?: Interpretation of Randomized Controlled Trials

Acta medica Lituanica
2010English

MDMA-assisted Psychotherapy for Treatment of PTSD: Study Design and Rationale for Phase 3 Trials Based on Pooled Analysis of Six Phase 2 Randomized Controlled Trials

Psychopharmacology
Pharmacology
2019English

Randomized Clinical Trials: How Long Should They Last?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials With Time‐to‐Event Outcomes

Oncologist
Cancer ResearchMedicineOncology
2019English

Mesalamine Did Not Prevent Recurrent Diverticulitis in Phase 3 Controlled Trials

Gastroenterology
HepatologyGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy